Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Propofol for Hemodynamic Stability in Cardiac Surgery
NCT06958913Completed
- Sponsor
- Pamukkale University
- Start
- May 2022
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of dexmedetomidine in ischemic heart disease (IHD), valvular heart disease (VHD) and aortic aneurysm (2 arms), sponsored by Pamukkale University. Primary endpoints: Systolic Blood Pressure, Diastolic Blood Pressure and 2 more. Started May 2022; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
ischemic heart disease (IHD)valvular heart disease (VHD)aortic aneurysm
Beyond the preview
Go deeper on NCT06958913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06958913.